Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach-Reference-Cited by-同舟云学术

Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach

Published:2018-12 Issue:1 Volume:13 Page:
ISSN:1940-0640
Container-title:Addiction Science & Clinical Practice
language:en
Short-container-title:Addict Sci Clin Pract

Author:

Bunting Amanda M.^ORCID,Oser Carrie B.,Staton Michele,Eddens Katherine S.,Knudsen Hannah

Funder

National Institute on Drug Abuse

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13722-018-0124-2.pdf

Reference53 articles.

1. Martins SS, Segura LE, Santaella-Tenorio J, et al. Prescription opioid use disorder and heroin use among 12–34 year-olds in the United States from 2002 to 2014. Addict Behav. 2017;65:236–41. https://doi.org/10.1016/j.addbeh.2016.08.033 .

2. Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001–2002 to 2012–2013 national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74(5):445–55. https://doi.org/10.1001/jamapsychiatry.2017.0113 .

3. Welty LJ, Harrison AJ, Abram KM, et al. Health disparities in drug- and alcohol-use disorders: a 12-year longitudinal study of youths after detention. Am J Public Health. 2016;106(5):872–80. https://doi.org/10.2105/AJPH.2015.303032 .

4. Cai R, Crane E, Poneleit K, Paulozzi L. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. J Pain Palliat Care Pharmacother. 2010;24(3):293–7. https://doi.org/10.3109/15360288.2010.503730 .

5. Van Handel MM, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr 1999. 2016;73(3):323–31. https://doi.org/10.1097/QAI.0000000000001098 .

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitioners;Health & Justice;2024-08-29

2. Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review;Frontiers in Public Health;2024-05-13

3. A Latent Profile Analysis of Substance Use and Post-Traumatic Stress on Substance Use Treatment Outcomes Among People Involved with the Justice System;Journal of Drug Issues;2024-04-22

4. Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia;Substance Use & Misuse;2024-04-18

5. Rural and urban clinician views on COVID-19’s impact on substance use treatment for individuals on community supervision in Kentucky;Health & Justice;2024-03-26